CLSA XPeng · XPEV

CLSA Lowers XPeng Price Target to HK$44

October 23, 2026 Analyst: Ding Luo 1 min read Reproduced verbatim
Rating
Buy
Target
HK$44
from HK$80 (−45%)
CLSA and XPeng logos

What the analyst said

CLSA analyst Ding Luo lowered the price target on XPeng (H-Shares) (9868:HK) (NYSE: XPEV) to HK$44 (from HK$80) while maintaining a Outperform (2) rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Track record

Firm track recordToo early to score CLSA: price targets are 12-month calls and fewer than 3 of its targets are a year old. 2 of its 8 open targets have already been reached. How we score

CLSA on XPeng

CLSA price targets on XPeng

3 calls from February 16, 2026 to October 23, 2026. The target went from HK$77 to HK$44 (−43%). The rating stayed Buy.

CLSA target
  1. October 23, 2026 This noteTarget cut from HK$80 (−45%)BuyHK$44
  2. March 23, 2026Target raised from HK$77 (+4%)BuyHK$80
  3. February 16, 2026Earliest call shownBuyHK$77
Share

Other analysts on XPeng

Goldman SachsBuy Cut price target, kept rating · Oct 23 Goldman SachsBuy Cut price target −11%, kept rating · Oct 23 $16from $18 JP MorganHold Downgraded · Sep 30 HK$45 JP MorganHold Downgraded · Sep 29 $11.50 Morgan StanleyBuy Cut price target, kept rating · Sep 15
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.